Echolight SpA announces distribution partnership in Brazil and Mexico.
Lecce, Italy, September 12, 2017: Echolight SpA, an innovative med-tech company developing the first radiation-free bone densitometer for the early diagnosis of osteoporosis, is pleased to announce the signing of a new partnership with the German company i²medi GmbH for the introduction and the promotion of its products in Brazil and Mexico. i²medi GmbH, through its local subsidiaries, will manage regulatory procedures for more click here, relationship with key opinion leaders, marketing & sales activities, training & education programs, and after-sales service.
Through this new partnership, in the growing Brazilian and Mexican markets, Echolight strengthens its global presence and demonstrates the huge success of EchoS: the only radiation-free bone densitometer for the early diagnosis of osteoporosis at lumbar vertebrae and femoral neck based on the proprietary method R.E.M.S. (Radiofrequency Echographic Multi Spectrometry), an innovative echographic approach for bone micro-architecture characterization through the exploitation of radiofrequency signals acquired during an echographic scan.
About Echolight SpA
Echolight is a high-tech biomed company for the development of the very first radiation free bone densitometer for the early diagnosis of osteoporosis. The company is in compliance with the standard: UNI CEI EN ISO 13485:2012; ISO 13485:2003; UNI EN ISO 9001: 2008; CE Mark Medical Device. Echolight Headquarters is based at Ecotekne University Campus in Lecce, Italy.
About i²medi GmbH
i²medi GmbH has been incorporated in 2014 as spin off from Nystrand Technologies company founded in 2002 by Mr. Emilio Lopez in Boca Raton, Miami (Florida, USA). i²medi is an international sales and marketing company focused on the introduction of cuttin-edge medical technologies in all major Latin American markets through highly experienced and qualified partners. It has two main offices: European offices are located in Berlin (Germany) while Latin American offices operate from Boca Raton (Florida, USA).